Hawaii’s Senate Judiciary Committee voted 5 to 0 today to approve a resolution calling on the U.S. Congress to deschedule cannabis, facilitate expungements and allow cannabis banking. The measure, Senate Resolution 58, was introduced by State Senator Joy San Buenaventura (D) and State Senator Angus McKelvey (D), alongside a companion proposal, Senate Concurrent Resolution 64, …
Oregon Marijuana Sales Top $219 Million Through March
Oregon’s legal marijuana market generated $219,561,595 in sales through the first three months of 2026, according to new data release by the state’s Liquor and Cannabis Commission. According to the latest figures, Oregon marijuana stores sold $74,595,450 worth of products in January, followed by $69,198,238 in February and $75,766,907 in March. That brings the year-to-date …
CBD Nasal Delivery Study Finds Stronger Brain Uptake and Symptom Improvement in Autism Model
A newly published study in Bioactive Materials finds that a nasal delivery system for cannabidiol (CBD) may significantly improve how efficiently the compound reaches the brain, while also reducing core autism-related symptoms. Researchers from the University of Haifa and Jerusalem College of Technology developed CBD-loaded polymeric micelles designed for intranasal, or nose-to-brain, delivery. The goal …
Edible Brands Executive Says FDA’s CBD Policy Could Support a Supplement-Style Edibles Framework, but Broader Reform Is Still Needed
A newly announced FDA policy on certain hemp-derived CBD products is drawing support from Edible Brands, which says the agency’s enforcement approach could help validate a supplement-style arrangement for edibles in healthcare settings. Edible Brands is the parent company of Edible Arrangements and Edibles.com. While the policy remains narrowly limited to specific Medicare-related circumstances, the …
CBD and BDNF Combination Shows Promise in Treating Alzheimer’s Disease
A study published today by the journal ACS Chemical Neuroscience by researchers from North Dakota State University found that an early intervention using cannabidiol (CBD) alongside brain-derived neurotrophic factor (BDNF) delivered through targeted nanoparticles reduced key markers tied to Alzheimer’s disease while also improving cognitive function. The study focused on a commonly used animal model …
Missouri Senate Approves Bill to Shift Intoxicating Hemp Products Into Marijuana Market
Missouri lawmakers are moving closer to overhauling the state’s hemp market, with the Senate giving approval to House Bill 2641 by a vote of 25 to 5, sending the amended proposal back to the House for a final concurrence vote. The measure previously cleared the House in February by a vote of 109 to 34, …
Wayland and Maricann Investor Lawsuits Settled for $8 Million, Claims Deadline Set for August 20
The settlement of multiple investor lawsuits tied to Wayland Group Corp. and Maricann Group Corp. is now finalized, paving the way for eligible investors to file claims for a share of the $8 million recovery. According to a court-approved notice issued April 1, the settlement applies to people and entities, other than excluded persons, who …
Louisiana Senate Committee Advances Bill Allowing Medical Marijuana for Terminally Ill Patients in Healthcare Facilities
A Louisiana Senate committee has advanced Senate Bill 270, advancing a proposal that would allow certain terminal patients to use medical marijuana while in a healthcare facility. The measure, filed by State Senator Katrina Jackson-Andrews (D), was reported with amendments on April 1 by the Senate Committee on Health and Welfare. The bill would require …
FDA Memo Eases Enforcement for Some CBD Products Used in Medicare-Linked Programs
The Food and Drug Administration (FDA) has issued a new memo outlining a shift in how it will approach enforcement for certain cannabidiol (CBD) products, indicating it will not enforce certain federal requirements under specific conditions tied to limited medical programs. In the April 1 memo, FDA Commissioner Martin Makary said the agency does not …
Centers for Medicare & Medicaid Services Launches Program Allowing Clinician-Supervised Hemp Products for Select Patients Starting Today
The Centers for Medicare & Medicaid Services (CMS) sent a press release this morning announcing the launch of a new pilot program that will allow certain participating healthcare organizations to furnish eligible hemp-derived products to patients under clinician supervision starting April 1. The CMS says the new initiative, called the Substance Access Beneficiary Engagement Incentive, …
Sponsored
